GC
FRTX

Globeflex Capital’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Globeflex Capital’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1
Closed -$1K – 552
2016
Q3 		$1K Buy
+1
New +$1.26K ﹤0.01% 442
2015
Q3 		– Hold
0
– – – 583
2015
Q2 		– Hold
0
– – – 602
2015
Q1 		– Hold
0
– – – 612
2014
Q4 		– Hold
0
– – – 481
2014
Q3 		– Hold
0
– – – 500

Other funds holding FRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Globeflex Capital's FRTX Position: Q4 2016 in Review

Globeflex Capital sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q4 2016, closing a stake of 1 share — an estimated $1K sold.

Globeflex Capital first reported a position in FRTX in Q3 2016 and held it in 1 quarter. The position peaked at $1K in Q3 2016. 26 funds tracked by Wall St. Rank hold FRTX as of Q4 2016.

  • Globeflex Capital reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Globeflex Capital sold 1 Fresh Tracks Therapeutics, Inc. Common Stock share in Q4 2016, an estimated $1K.
  • Globeflex Capital first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q3 2016 and held it in 1 quarter.
  • Globeflex Capital's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $1K in Q3 2016.
  • 26 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Globeflex Capital's 13F filing for Q4 2016, filed 13 Feb 2017.